15
Apr

German drugmaker Bayer is investing $100 million in its Berkeley, CA, R&D outpost, blueprinting a new testing facility to support its work developing new treatments for hemophilia.

…read more

Source: Bayer pours $100M into Bay Area R&D with eyes on hemophilia

    

0 No comments